Deal 115 - IPO 4 Therapeutics (CCCC) -money for cancer treatment
Stock market. Stocks. IPO of C4 Therapeutics (CCC) — October 02, 2020 will start trading on the US NASDAQ stock exchange for the company that develops new cancer treatments by using the natural regulation of protein in the body. The placement is underwritten by Jefferies, Evercore ISI, BMO Capital Markets and UBS Investment Bank. The deadline for submitting an application with the broker is 20-00 Moscow time 30.09.2020, the placement date is 01.10.2020.
2% of the Fund will be invested in shares of this company. A detailed report on the transaction, or "opportunity card", for all partners of our Fund will be provided in PDF format. Anyone who wants to receive them is asked to write with private messages.
2% of the Fund will be invested in shares of this company. A detailed report on the transaction, or "opportunity card", for all partners of our Fund will be provided in PDF format. Anyone who wants to receive them is asked to write with private messages.